Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers
Diego A. Pedroza(Texas Tech University), Jeffrey M. Rosen(Baylor College of Medicine)
Cited by 1
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
|Breast Cancer Research|2009|298
Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
|Journal of Mammary Gland Biology and Neoplasia|2010|243
Intratumoral Heterogeneity in a <i>Trp53</i> -Null Mouse Model of Human Breast Cancer
|Cancer Discovery|2015|73